T. Rowe Price Associates »

Dianthus Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-12-31 $207k 9.5k 21.86
2024-09-30 $215k 7.8k 27.49

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Alphabet Comm Stk (GOOGL)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Tesla Comm Stk (TSLA)
Broadcom Comm Stk (AVGO)
Unitedhealth Group Comm Stk (UNH)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Servicenow Comm Stk (NOW)

View all positions for T. Rowe Price Associates

Top funds holding Dianthus Therapeutics

FMR
Avidity Partners Management
Fairmount Funds Management
Bain Capital Life Sciences Investors
Octagon Capital Advisors
RA Capital Management
VR Adviser
BlackRock
TCG Crossover Management
Vanguard Group
Braidwell
Alliancebernstein
Henderson Group
5AM Venture Management
State Street Corporation

View all funds holding Dianthus Therapeutics